BA, Brandeis University
JD, Northeastern University
Areas of Interest
- Email email@example.com
Luba Greenwood has deep industry experience and expertise in mergers & acquisitions and strategic partnerships, ranging from billion-dollar deals to small strategic alliances. She advises large multinational corporations, start-ups, financial firms, and private equity and venture capital funds in biotechnology, pharma, technology, energy, finance, and defense industries, serving as a strategic advisor on deal structures, valuation, exit and global strategy, risk analysis and due diligence, negotiation strategy, and early stage and capital investments. Ms. Greenwood served as a Senior Mergers & Acquisitions counsel at Pfizer Inc., where she advised on risks in complex commercial transactions including mergers and acquisitions, asset purchases, joint ventures, divestitures, technology transfers, co-commercialization and co-development, collaboration, and in-licensing and our-licensing agreements and venture capital investments, working with cross-functional teams in business development, tax, antitrust, litigation, finance, R&D, and commercial. Prior to Pfizer, Ms. Greenwood practiced law at Wilmer Cutler Pickering Hale and Dorr in the Litigation and Securities Departments where she represented clients in securities, intellectual property, regulatory, and litigation matters.
Luba Greenwood advises a number of early-stage technology companies, leading business development and strategy for a biotechnology company and serving as head of corporate development at a private merchant bank.
Luba is an adjunct professor at Boston University School of Management where she teaches Business Law, and Boston University Law School where she teaches a course on the Life Sciences. She also lectures at Bentley University. She is a frequent speaker on topics relating to innovation, healthcare, biotechnology, intellectual property, and legal and regulatory risks.
Luba serves on the board of the Longwood Symphony Orchestra, is a Co-chair of MassBios Entrepreneurs University, mentor for the MIT 100K Entrepreneurship Competition, a judge for MassChallenge and the Young Entrepreneurs Initiative, and on a Steering Committee of the Boston Bar Association.
In 2014, Luba she received the Science Club for Girls Catalyst Award for her commitment to fostering women talent and advocating for women in science and technology.
Representing Life Sciences Companies: Biotechnology, Pharmaceuticals and Medical Devices (S): LAW JD 907
Biotechnology and Pharmaceuticals are two of the fastest growing industries in the U.S., and the legal issues that arise in connection with representing them are complex and evolving. This seminar will focus on the transactional, intellectual property, and regulatory legal issues that challenge lawyers working with clients in these industries. We will begin with an overview of these industries, including a basic review of the sciences underpinning them (intended for non-scientists). We will then delve into complex legal issues such as licensing, collaborations, and consortium building; academic-industry interactions; the drug and biologic regulatory approval process; issues arising in clinical trials; and legal issues arising in the manufacture and distribution of life sciences products. If time permits, we will also examine the medical device industry and the ways in which that industry differs from the biopharmaceutical industry. In lieu of an exam, students will prepare a 25 page, journal-worthy article addressing a legal topic of the student's selection. PREREQUISITE: No scientific background will be required, but students will benefit from prior or contemporaneous coursework in intellectual property. LIMITED WRITING REQUIREMENT OPTION: A limited number of students may be permitted to satisfy the upper-class writing requirement with the approval of the Associate Dean for Academic Affairs. NOTE: This seminar satisfies the upper-class Professional Skills requirement. This course may not be used to satisfy both the Writing and Professional Skill requirements. GRADING NOTICE: This course does not offer the CR/NC/H option. OFFERING PATTERN: This class is not offered every year. Students are advised to take this into account when planning their long-term schedule. ** A student who fails to attend the initial meeting of a seminar (designated by an (S) in the title), or to obtain permission to be absent from either the instructor or the Registrar, may be administratively dropped from the seminar. Students who are on a wait list for a seminar are required to attend the first seminar meeting to be considered for enrollment.SPRG 2017: LAW JD 907 A1 , Jan 18th to Apr 26th 2017
|Wed||6:30 pm||8:30 pm||3||Luba Greenwood||LAW||416|
In the Media
- November 16, 2017
IRX Therapeutics Appoints Luba Greenwood to Board of Directors Business Wire read more